Published on 25 Mar 2024 on Benzinga
Altamira Therapeutics Ltd. CYTO shares are trading higher Monday after the company announced that it has entered into a collaboration agreement with Univercells Group to evaluate the use of the company’s proprietary SemaPhore platform for the delivery of mRNA vaccines.
The Details: